ERD

MIRACLE | MIRACLE the platform for virtual biopsies; introducing Metabolic MRI-as-a-Service for oncologic care

01-05-2022

-

30-04-2025

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

HepatoMetaboPath | Cellular and molecular mechanisms of metabolic immune activation triggering non-alcoholic steatohepatitis (NASH) and HCC

01-07-2016

-

30-06-2021

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

COMBIOSCOPY | Computational Biophotonics for Endoscopic Cancer Diagnosis and Therapy

01-07-2015

-

31-12-2020

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

ReTuBi | Towards outstanding research and training in tumour biology at IMM

01-01-2016

-

31-12-2018

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

DECODE | Decoding Context-Dependent Genetic Networks in vivo

01-07-2019

-

30-06-2025

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

RNAEDIT | RNA EDITING IN HEALTH AND DISEASE

01-01-2016

-

31-12-2021

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

HOXA9 degradome | Deciphering the machinery involved in stability of the transcription factor HOXA9.

07-11-2016

-

05-09-2020

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

VIBEBOT | Vibrational Micro-robots in Viscoelastic Biological Tissues

01-01-2023

-

31-12-2027

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

AngioMature | Mechanisms of vascular maturation and quiescence during development, homeostasis and aging

01-08-2018

-

31-10-2024

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

NEURAL SPICING | Neural Spectral Image Decoding

01-05-2021

-

30-04-2026

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

REGiREG | Regulating the immune regulators: targeting adaptive immune control

01-07-2015

-

30-06-2021

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

CENTRIC-BRAIN | Characterizing and harnessing tumor-reactive T cells in the brain

01-10-2024

-

30-09-2029

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

ELIMINATE | Development of strategies to eliminate cancer cells from the bone marrow

01-02-2018

-

31-01-2024

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

nanoVAST | nanoVAST: a novel, non- viral LNP for precision payload delivery of genome editors and other cargo

01-10-2022

-

31-03-2024

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

EPIMODKIT | Generating monoclonal antibodies that selectively and specifically recognize epitranscriptomic modifications.

01-07-2020

-

31-12-2021

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

CrispSCNAs | Dissecting the Functional and Therapeutic Impact of Somatic Copy Number Alterations (SCNAs)

01-01-2021

-

31-12-2025

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

MuscleAntiVirus | Skeletal Muscles Antagonize T Cell Exhaustion in Chronic Viral Infections

01-06-2022

-

31-05-2027

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

SHATTER-AML | Decoding consequences of complex chromosomal aberrations by multi-modal single-cell deconstruction to overcome treatment-resistance cancer

01-07-2022

-

30-06-2027

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

DRILL | Decoding Requirements for Infiltration of T ceLLs into solid tumors

01-01-2023

-

31-12-2027

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

CASSIS | A single-cell atlas of human soft tissue sarcoma ecosystems with focus on mechanisms of immune evasion

01-02-2023

-

31-01-2025

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

engineereD to Clear | Investigation on the vaccination potential of IL4i1 deficient dendritic cells in Chronic lymphocytic leukemia

01-10-2022

-

30-09-2024

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

ACHILLEUS | Next-Generation Drug Discovery Platform for Targeting Cancer Stem Cell Pathways

01-11-2022

-

31-10-2025

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

CancAHR | Understanding the complex biology of AHR activation in cancer

01-01-2023

-

31-12-2027

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

MRDAML | Deciphering the mechanistic basis of minimal residual disease and treatment resistance in acute myeloid leukemia

01-09-2023

-

31-08-2025

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

TAIPO | Trustworthy AI tools for personalized oncology

01-05-2023

-

30-04-2028

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

REMATCH | Image-based analysis for drug discovery and repurposing

01-08-2018

-

31-01-2020

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

BARCODED-CELLTRACING | Endogenous barcoding for in vivo fate mapping of lineage development in the blood and immune system

01-07-2017

-

30-06-2023

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

C18Signaling | Regulation of Cellular Growth and Metabolism by C18:0

01-03-2017

-

31-08-2023

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

EVI1inCancer | Overcoming the epigenetic and therapeutic barrier of EVI1-overexpressing cancers

01-06-2016

-

31-05-2021

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

BRAIN-MATCH | Matching CNS Lineage Maps with Molecular Brain Tumor Portraits for Translational Exploitation

01-05-2019

-

31-12-2024

Show more information

Organisation DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

Projects overview

Selected filters:

MIRACLE | MIRACLE the platform for virtual biopsies; introducing Metabolic MRI-as-a-Service for oncologic care

HepatoMetaboPath | Cellular and molecular mechanisms of metabolic immune activation triggering non-alcoholic steatohepatitis (NASH) and HCC

COMBIOSCOPY | Computational Biophotonics for Endoscopic Cancer Diagnosis and Therapy

ReTuBi | Towards outstanding research and training in tumour biology at IMM

DECODE | Decoding Context-Dependent Genetic Networks in vivo

RNAEDIT | RNA EDITING IN HEALTH AND DISEASE

HOXA9 degradome | Deciphering the machinery involved in stability of the transcription factor HOXA9.

VIBEBOT | Vibrational Micro-robots in Viscoelastic Biological Tissues

AngioMature | Mechanisms of vascular maturation and quiescence during development, homeostasis and aging

NEURAL SPICING | Neural Spectral Image Decoding

REGiREG | Regulating the immune regulators: targeting adaptive immune control

CENTRIC-BRAIN | Characterizing and harnessing tumor-reactive T cells in the brain

ELIMINATE | Development of strategies to eliminate cancer cells from the bone marrow

nanoVAST | nanoVAST: a novel, non- viral LNP for precision payload delivery of genome editors and other cargo

EPIMODKIT | Generating monoclonal antibodies that selectively and specifically recognize epitranscriptomic modifications.

CrispSCNAs | Dissecting the Functional and Therapeutic Impact of Somatic Copy Number Alterations (SCNAs)

MuscleAntiVirus | Skeletal Muscles Antagonize T Cell Exhaustion in Chronic Viral Infections

SHATTER-AML | Decoding consequences of complex chromosomal aberrations by multi-modal single-cell deconstruction to overcome treatment-resistance cancer

DRILL | Decoding Requirements for Infiltration of T ceLLs into solid tumors

CASSIS | A single-cell atlas of human soft tissue sarcoma ecosystems with focus on mechanisms of immune evasion

engineereD to Clear | Investigation on the vaccination potential of IL4i1 deficient dendritic cells in Chronic lymphocytic leukemia

ACHILLEUS | Next-Generation Drug Discovery Platform for Targeting Cancer Stem Cell Pathways

CancAHR | Understanding the complex biology of AHR activation in cancer

MRDAML | Deciphering the mechanistic basis of minimal residual disease and treatment resistance in acute myeloid leukemia

TAIPO | Trustworthy AI tools for personalized oncology

REMATCH | Image-based analysis for drug discovery and repurposing

BARCODED-CELLTRACING | Endogenous barcoding for in vivo fate mapping of lineage development in the blood and immune system

C18Signaling | Regulation of Cellular Growth and Metabolism by C18:0

EVI1inCancer | Overcoming the epigenetic and therapeutic barrier of EVI1-overexpressing cancers

BRAIN-MATCH | Matching CNS Lineage Maps with Molecular Brain Tumor Portraits for Translational Exploitation